Form 4 for EW Edwards Lifesciences
Accepted 2022-05-10 00:00:00 ET · period of report 2022-05-07 · accession 0001225208-22-006815 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-10 | 2022-05-07+ | EW | WANG HUIMIN | CVP, Japan, Intercontinental | F - Tax | $100.52 | -4,573 | 100.3K | -4% | -$459.7K |
| DM | 2022-05-10 | 2022-05-08+ | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $12.17 | +10.6K | 104.0K | +11% | +$129.4K |
| D | 2022-05-10 | 2022-05-09 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | S - Sale+OE | $98.71 | -3,675 | 100.3K | -4% | -$362.8K |
| DM | 2022-05-10 | 2022-05-08+ | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $0.00 | -10.6K | 33.1K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-07 | F | D | 363 | $100.52 | 97,553.80 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-08 | M | A | 6,956 | $0.00 | 104,509.80 | D | — | — | (F1) On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4. |
| 3 | Common | Common Stock | 2022-05-08 | F | D | 4,210 | $100.52 | 100,299.80 | D | — | — | |
| 4 | Common | Common Stock | 2022-05-09 | M | A | 3,675 | $35.20 | 103,974.80 | D | — | — | |
| 5 | Common | Common Stock | 2022-05-09 | S | D | 3,675 | $98.71 | 100,299.80 | D | — | — | |
| 6 | Derivative | Performance Rights | 2022-05-08 | M | D | 6,956 | $0.00 | 0 | D | — · 2022-05-08 to 2026-05-07 | 6,956 Common Stock | (F1) On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4. |
| 7 | Derivative | Employee Stock Option (Right to Acquire) | 2022-05-09 | M | D | 3,675 | $0.00 | 33,075 | D | $35.20 · 2016-06-12 to 2023-05-11 | 3,675 Common Stock |